Core
Precision guided therapy system
Core
Precision guided therapy system
The Core precision guided therapy systems offer the choice of imaging and physiology on a single integrated platform.¹ Core helps provide clarity in your approach, confidence in your decisions, and convenience in your diagnostic and interventional workflows.
Features
One system, many choices
Core supports a full suite of imaging and physiology analysis tools including FFR lesion assessment, iFR modality, iFR Scout, digital IVUS, high-resolution rotational IVUS, ChromaFlo stent apposition assessment, VH IVUS automatic tissue classification, and Pioneer Plus IVUS for peripheral procedures.*
iFR modality simplifies workflow
iFR modality simplifies workflow by providing a hyperemia-free measurement to assess lesion significance in as few as five heartbeats. Philips’ proprietary iFR modality has a robust body of clinical evidence with over 9,000 patients in numerous studies and peer-reviewed journal articles.⁵
iFR Scout pullback
The iFR Scout pullback shows the most significant gradient in the mid-vessel lesion with diffuse proximal disease.
Specifications
- Power requirements
- System input
- 100, 120V, 220, 240VAC, 50/60Hz, 1000VA Volts, volt alternating current, hertz, volt-ampere
- Monitor
- 100V – 240V 50/60Hz, 39W Volts, volt alternating current, hertz, volt-ampere
- Workstation
- 100 – 240V, 50/60Hz, 550VA, 825VA Volts, volt alternating current, hertz, volt-ampere
- Ordering Information
- Core system
- CORE01
- Control pad
- CPADO1
- Bedrail mount
- MNTO1
- Monitor mount
- MNTO2
- Dimensions
- Workstation
- H=17", W=10", D=16.5" Inches
- Control pad (optional)
- H=2.75", W=10.5", D=8.3" Inches
- Control room controller
- H=5", W=15", D=10" Inches
- Monitor
- H=15"– 19" (depending upon the stand extension), W=15.8", D=9.7" Inches
- Connection box
- H=9.85", W=2.95", D=7.75" Inches
Related products
- The SyncVision precision guidance system streamlines lesion assessment, simplifies vessel sizing, and enables precise therapy delivery in conjunction with the existing fluoroscopic image stream.
- The Eagle Eye Platinum digital IVUS catheter is the #1 choice of physicians for intravascular imaging (in the US).* As a unique plug-and-play intravascular imaging catheter it is designed for ease of use and deliverability. Features include a soft tapered tip, GlyDx hydrophilic coating for increased lubricity, a long, rapid exchange lumen for improved pushability, three radiopaque markers, and compatibility with SyncVision for co-registration with angiography.
- The Eagle Eye Platinum ST digital IVUS catheter offers a 2.5 mm tip-to-imaging distance designed to assess more of the vessel than standard catheters by providing a closer visualization of highly stenosed lesions and distal anatomy. The short tip catheter fits through all 5F guides and has all features of our top-selling Eagle Eye Platinum model, including plug-and-play simplicity, three radiopaque markers, GlyDx hydrophilic coating, and SyncVision compatibility.*
- For over 20 years Philips has led the way in physiology, putting patients first through continuous innovation. Now introducing our 10ᵗʰ generation physiology wire: Verrata Plus.
- Core Mobile is designed to power the future of precision guided therapy and offers the choice of imaging and physiology on a single mobile platform.¹ Core Mobile also provides clarity in your approach and confidence in your results by offering additional information during the diagnostic phase, assisting in intervention decisions.
Disclaimer
1. 505-0100.21, Operator's Manual, Core Integrated, 3.4X (p. 18); 505-0101.16, Operator's Manual, s5 Series FFR_iFR Option, v3.4x (p.15).
2. VAL RPT, S5-Core V3.4 SW with Core Control Pad, 215-0007.02.
3. Product Spec. 809480-001, 202-0407.01.
4. Requirements Specification Meridian VH SW, 806000-004 (pg 84).
5. An iFR cut-point of 0.89 matches best with an FFR ischemic cut-point of 0.80 with a specificity of 87.8% and sensitivity of 73.0%. (iFR Operator’s Manual 505-0101.23)
6. N Engl J Med. 2012;367(11):991-1001.
7. Witzenbichler B et al. Relationship Between Intravascular Ultrasound Guidance and Clinical Outcomes After Drug-Eluting Stents: The ADAPT-DES Study. Circulation 2014 Jan: 129,4;463-470
8. Ahn et al. Meta-Analysis of Outcomes After Intravascular Ultrasound Guided Versus Angiography-Guided Drug-Eluting Stent Implantation in 26,503 Patients Enrolled in Three Randomized Trials and 14 Observational Studies. Am J Cardiol 2014; 113:1338-1347